MEDFORD, Mass. — A European biotech company on Thursday opened the world’s first amniotic stem cell bank in Medford.
The company, Biocell Center, does work in fertility and infant care. CEO Kate Torchilin said the new facility will be the first in the world to collect and store amniotic stem cells for their unique therapeutic properties:
“That is the mission of our company: to offer the opportunity to store the sample to medical centers and physicians who think their patients will benefit from this service,” Torchilin said.
Biocell Center has offices in Italy and Switzerland, but says it’s opening the amniotic stem cell bank in Medford because of the strong life sciences sector in Massachusetts.